Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Dyslipidemia

  Free Subscription


21.04.2025

6 Atherosclerosis
4 Curr Opin Lipidol
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Atherosclerosis

  1. MICHIKURA M, Ogura M, Hori M, Matsuki K, et al
    Association of Achilles tendon thickness with lipid profile and carotid IMT in patients with familial hypercholesterolemia.
    Atherosclerosis. 2025;403:119173.
    PubMed         Abstract available

  2. STONEHOUSE W, Benassi-Evans B, Louise J
    The effects of a novel nutraceutical combination on low-density lipoprotein cholesterol and other markers of cardiometabolic health in adults with hypercholesterolaemia: A randomised double-blind placebo-controlled trial.
    Atherosclerosis. 2025;403:119177.
    PubMed         Abstract available

  3. BRINTON EA, Eckel RH, Gaudet D, Ballantyne CM, et al
    Familial chylomicronemia syndrome and treatments to target hepatic APOC3 mRNA.
    Atherosclerosis. 2025;403:119114.
    PubMed         Abstract available

  4. DANIELE T, Laura D, Miriam L, Diane B, et al
    The vicious circle of chronic kidney disease and hypertriglyceridemia: What is first, the hen or the egg?
    Atherosclerosis. 2025;403:119146.
    PubMed         Abstract available

  5. IYEN B, Qureshi N, Kai J, Capps N, et al
    Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): A retrospective cohort study of individuals with FH in UK primary care and the UK Simon Broome register, linked with national
    Atherosclerosis. 2025;403:119142.
    PubMed         Abstract available

  6. LIN J, Ji Y, Wang G, Ma X, et al
    Efficacy and safety of ongericimab in Chinese patients with heterozygous familial hypercholesterolemia: A randomized, double-blind, placebo-controlled phase 3 trial.
    Atherosclerosis. 2025;403:119120.
    PubMed         Abstract available


    Curr Opin Lipidol

  7. HEGELE RA
    What is the phenotype of heterozygous lipoprotein lipase deficiency?
    Curr Opin Lipidol. 2025;36:96-103.
    PubMed         Abstract available

  8. ISON HE, Helm B, Kringlen G, Crawford P, et al
    Navigating variants of uncertain significance in genetic dyslipidemia: how to assess and counsel patients.
    Curr Opin Lipidol. 2025;36:49-54.
    PubMed         Abstract available

  9. BIRKENHEAD K, Sullivan D, Watts GF, Sarkies MN, et al
    Implementation science and genetic testing for familial hypercholesterolemia.
    Curr Opin Lipidol. 2024 Nov 26. doi: 10.1097/MOL.0000000000000967.
    PubMed         Abstract available

  10. PAQUETTE M, Guay SP, Baass A
    Genetic determinants of pancreatitis risk in hypertriglyceridemia.
    Curr Opin Lipidol. 2024 Nov 11. doi: 10.1097/MOL.0000000000000962.
    PubMed         Abstract available


    PLoS One

  11. SU Z, Ling Z, Chen H, Hu L, et al
    Association between hyperlipidemia and nephrolithiasis: A comprehensive bioinformatics analysis deciphering the potential common denominator pathogenesis.
    PLoS One. 2025;20:e0321734.
    PubMed         Abstract available

  12. PARK J, Kim DY, Suh M, Kim YH, et al
    Assessing gastric cancer risk through longitudinal health check-up data: Insights from a national cohort study in South Korea.
    PLoS One. 2025;20:e0312861.
    PubMed         Abstract available

  13. COLMENARES-MEJIA CC, Garcia-Suaza AF, Rodriguez-Lesmes P, Lochmuller C, et al
    Predicting diabetes mellitus metabolic goals and chronic complications transitions-analysis based on natural language processing and machine learning models.
    PLoS One. 2025;20:e0321258.
    PubMed         Abstract available

  14. RASTOGI A, Ravindranath V, Dubey A, Gude D, et al
    A real-world multicenter cross-sectional observational study to assess the clinical profile of peripheral neuropathy in patients with diabetes.
    PLoS One. 2025;20:e0312085.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.